Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00237770Phase 3Completed
A Phase 3 trial of ng-nitro-l-arginine methyl ester in orthostatic hypotension (OH), sponsored by United States Department of Veterans Affairs. Started Jun 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00237770.